Webinar on Anaphylaxis to COVID-19 Vaccines
Dr. Kathy Edward's presented on anaphylaxis to COVID-19 vaccines during an meta-DSMB meeting on January 13th, 2021. For the recording, please click here.
VSQ – Q1 2021
The Q1 2021 issue of the Vaccine Safety Quarterly (VSQ) newsletter is now available here!
COVID-19 AESI List 2nd Quarterly Update (December 2020)
SPEAC has completed a second update of the COVID-19 clinical literature covering the period of August 8 through November 13th 2020. Based on this review three entities are being added…
BC Case Definition: Acute Respiratory Distress Syndrome (ARDS)
This is a The Brighton Collaboration Case Definition of the term “Acute Respiratory Distress Syndrome (ARDS)” to be utilized in the evaluation of adverse events following immunization. The case definition was…
BC Case Definition: Multisystem Inflammatory Syndrome in Children and Adults (MIS-C/A)
This is a Brighton Collaboration Case Definition of the terms "Multisystem Inflammatory Syndrome in Children (MIS-C)" and "Multisystem Inflammatory Syndrome in Adults (MIS-A)" to be utilized in the evaluation of…
Ensuring Safety of COVID-19 Vaccines: Q&A with Robert Chen
Robert Chen, the Scientific Director of Brighton Collaboration, discussed the safety profiles of COVID-19 vaccines with the Coalition for Epidemic Preparedness Innovations (CEPI). To view the article click here.
AESI Case Definition Companion Guide: Acute Myelitis
This post contains the Companion Guide for Acute Myelitis. This and other companion guides have been created as part of the CEPI-funded SPEAC project. They contain resources and tools specific…
Addendum to Priority List of Adverse Events of Special Interest: COVID-19
The Coalition for Epidemic Preparedness Innovations (CEPI) has contracted with the Brighton Collaboration, through the Task Force for Global Health (TFGH), to harmonize the safety assessment of CEPI-funded vaccines via its Safety Platform for…
Vaccine-associated Enhanced Disease: Case Definition and Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data
This is a Brighton Collaboration case definition of the term “Vaccine-associated Enhanced Disease” (VAED) to be utilized in the evaluation of adverse events following immunization. The case definition was developed…
VSQ – Q4 2020
The Q4 2020 issue of the Vaccine Safety Quarterly (VSQ) newsletter is now available here!